Chronic Cough Management
Diagnosis
- Eosinophil count testing should be performed in patients with persistent cough following viral infections, as non-asthmatic eosinophilic bronchitis (NAEB) accounts for 10-30% of chronic cough cases and requires inhaled corticosteroid treatment 1, 2
- Sputum eosinophilia (>3% non-squamous cells) is the key diagnostic marker for identifying eosinophilic airway inflammation, and if present without bronchial hyperresponsiveness, diagnose as NAEB 2
- Elevated IgE levels may indicate atopic cough or allergic triggers, but IgE testing is not diagnostic on its own 2
- If no sputum eosinophilia is present, consider other causes: post-infectious cough, upper airway cough syndrome, gastroesophageal reflux 3, 4
- The methacholine challenge test is the gold standard for detecting bronchial hyperresponsiveness, with a high negative predictive value that essentially excludes asthma 5
- A positive methacholine challenge test indicates bronchial hyperresponsiveness but is not diagnostic of asthma alone, and normal spirometry does not exclude bronchial hyperresponsiveness 5
Treatment
- First-line treatment for eosinophilic bronchitis is inhaled corticosteroids, with a typical regimen of Budesonide 400 μg twice daily or equivalent, leading to significant reduction in sputum eosinophil count and improvement in cough typically within 2-4 weeks 2
- Consider inhaled ipratropium bromide as it may attenuate post-infectious cough, and for severe paroxysms of cough, a short course of oral prednisone (30-40mg daily) may be considered 4
- Antibiotics have no role in post-infectious cough management unless bacterial infection is confirmed 4
- If cough persists, consider a trial of inhaled corticosteroids, as a positive response may indicate either asthma or non-asthmatic eosinophilic bronchitis 5
Diagnostic Challenges and Treatment Considerations
- Sputum induction requires specialized equipment and expertise, and failure to identify eosinophilic inflammation may lead to inappropriate treatment, while response to inhaled corticosteroids confirms the diagnosis of eosinophilic bronchitis 2
- Duration of treatment is not well established; consider tapering once symptoms resolve, and some patients may require long-term inhaled corticosteroid therapy 2
- Multiple pathogenic factors may contribute to postinfectious cough, including postviral airway inflammation, bronchial hyperresponsiveness, mucus hypersecretion, and impaired mucociliary clearance 4
- Upper airway cough syndrome, gastroesophageal reflux, and non-asthmatic eosinophilic bronchitis can coexist with or mimic bronchial hyperresponsiveness 6
Follow-up
- Monitor sputum eosinophil counts to confirm treatment response, and consider occupational or environmental triggers if symptoms recur 2
- If cough persists beyond 8 weeks, consider diagnoses other than postinfectious cough, and the American College of Chest Physicians recommends bronchoprovocation challenge (BPC) testing to evaluate bronchial hyperresponsiveness in patients with chronic cough following a viral infection 5, 7
- A positive bronchoprovocation test alone is not diagnostic of asthma - definitive diagnosis requires resolution of cough with specific antiasthmatic therapy, and if bronchoprovocation challenge testing is not available, consider an empiric trial of inhaled ipratropium as first-line treatment for postinfectious cough 5, 8